- Home
- PHIO vs NBY Comparison
PHIO vs NBY Comparison
Compare PHIO & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- NBY
- Stock Information
- Founded
- PHIO 2011
- NBY 2000
- Country
- PHIO United States
- NBY United States
- Employees
- PHIO N/A
- NBY N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- NBY
- Sector
- PHIO Health Care
- NBY
- Exchange
- PHIO Nasdaq
- NBY Nasdaq
- Market Cap
- PHIO 13.7M
- NBY 15.7M
- IPO Year
- PHIO N/A
- NBY 2007
- Fundamental
- Price
- PHIO $2.31
- NBY $1.19
- Analyst Decision
- PHIO Strong Buy
- NBY Strong Buy
- Analyst Count
- PHIO 3
- NBY 1
- Target Price
- PHIO $10.67
- NBY $0.85
- AVG Volume (30 Days)
- PHIO 161.3K
- NBY 1.2M
- Earning Date
- PHIO 11-13-2025
- NBY 11-06-2025
- Dividend Yield
- PHIO N/A
- NBY N/A
- EPS Growth
- PHIO N/A
- NBY N/A
- EPS
- PHIO N/A
- NBY 0.41
- Revenue
- PHIO N/A
- NBY $9,781,000.00
- Revenue This Year
- PHIO N/A
- NBY $23.91
- Revenue Next Year
- PHIO N/A
- NBY $32.05
- P/E Ratio
- PHIO N/A
- NBY $3.52
- Revenue Growth
- PHIO N/A
- NBY 113.47
- 52 Week Low
- PHIO $0.97
- NBY $0.46
- 52 Week High
- PHIO $9.79
- NBY $4.44
- Technical
- Relative Strength Index (RSI)
- PHIO 54.93
- NBY 42.16
- Support Level
- PHIO $2.28
- NBY $1.22
- Resistance Level
- PHIO $2.45
- NBY $1.64
- Average True Range (ATR)
- PHIO 0.12
- NBY 0.22
- MACD
- PHIO 0.02
- NBY -0.17
- Stochastic Oscillator
- PHIO 54.72
- NBY 0.82
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.